IE42952B1 - Tablet formulation - Google Patents
Tablet formulationInfo
- Publication number
- IE42952B1 IE42952B1 IE272/76A IE27276A IE42952B1 IE 42952 B1 IE42952 B1 IE 42952B1 IE 272/76 A IE272/76 A IE 272/76A IE 27276 A IE27276 A IE 27276A IE 42952 B1 IE42952 B1 IE 42952B1
- Authority
- IE
- Ireland
- Prior art keywords
- sulphonamide
- tablet
- tablet according
- particle size
- disintegrating agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB6174/75A GB1533243A (en) | 1975-02-13 | 1975-02-13 | Tablet formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE42952L IE42952L (en) | 1976-08-13 |
| IE42952B1 true IE42952B1 (en) | 1980-11-19 |
Family
ID=9809772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE272/76A IE42952B1 (en) | 1975-02-13 | 1976-02-12 | Tablet formulation |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS51106711A (https=) |
| BE (1) | BE838507A (https=) |
| CA (1) | CA1052267A (https=) |
| DE (1) | DE2605656A1 (https=) |
| DK (1) | DK57376A (https=) |
| FI (1) | FI760340A7 (https=) |
| FR (1) | FR2300550A1 (https=) |
| GB (1) | GB1533243A (https=) |
| HU (1) | HU171201B (https=) |
| IE (1) | IE42952B1 (https=) |
| IL (1) | IL49024A (https=) |
| NL (1) | NL7601423A (https=) |
| SE (1) | SE7601564L (https=) |
| ZA (1) | ZA76829B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1601833A (en) * | 1978-02-06 | 1981-11-04 | Wellcome Found | Antacid formulation |
| ZA822995B (en) * | 1981-05-21 | 1983-12-28 | Wyeth John & Brother Ltd | Slow release pharmaceutical composition |
| US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| MY110880A (en) * | 1991-01-30 | 1999-06-30 | The Wellcome Foundation Ltd | Water-dispersible tablets |
| US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| US20040109889A1 (en) | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1460302A (en) * | 1973-05-23 | 1977-01-06 | Wellcome Found | Tablet formulation |
| GB1499672A (en) * | 1974-02-14 | 1978-02-01 | Wellcome Found | Tablet formulation |
-
1975
- 1975-02-13 GB GB6174/75A patent/GB1533243A/en not_active Expired
-
1976
- 1976-02-12 IE IE272/76A patent/IE42952B1/en unknown
- 1976-02-12 JP JP51014332A patent/JPS51106711A/ja active Pending
- 1976-02-12 FI FI760340A patent/FI760340A7/fi not_active Application Discontinuation
- 1976-02-12 HU HU76WE00000534A patent/HU171201B/hu unknown
- 1976-02-12 BE BE164281A patent/BE838507A/xx unknown
- 1976-02-12 DK DK57376*#A patent/DK57376A/da unknown
- 1976-02-12 IL IL7649024A patent/IL49024A/xx unknown
- 1976-02-12 FR FR7603829A patent/FR2300550A1/fr active Granted
- 1976-02-12 NL NL7601423A patent/NL7601423A/xx not_active Application Discontinuation
- 1976-02-12 CA CA245,882A patent/CA1052267A/en not_active Expired
- 1976-02-12 SE SE7601564A patent/SE7601564L/xx unknown
- 1976-02-12 DE DE19762605656 patent/DE2605656A1/de not_active Withdrawn
- 1976-02-12 ZA ZA760829A patent/ZA76829B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK57376A (da) | 1976-08-14 |
| CA1052267A (en) | 1979-04-10 |
| DE2605656A1 (de) | 1976-08-26 |
| FR2300550B1 (https=) | 1979-09-21 |
| FI760340A7 (https=) | 1976-08-14 |
| ZA76829B (en) | 1977-09-28 |
| BE838507A (fr) | 1976-08-12 |
| IL49024A0 (en) | 1976-04-30 |
| FR2300550A1 (fr) | 1976-09-10 |
| IL49024A (en) | 1979-03-12 |
| HU171201B (hu) | 1977-11-28 |
| AU1110876A (en) | 1977-08-18 |
| SE7601564L (sv) | 1976-08-16 |
| NL7601423A (nl) | 1976-08-17 |
| GB1533243A (en) | 1978-11-22 |
| IE42952L (en) | 1976-08-13 |
| JPS51106711A (https=) | 1976-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4209513A (en) | Tablet formulation | |
| US4562024A (en) | Process for preparing granulate containing poorly compressible medicinally active matter | |
| AU611999B2 (en) | Pharmaceutical granulate | |
| US4950484A (en) | Pharmaceutical tablet, pharmaceutical granulate and process for their preparation | |
| US3622677A (en) | Compressed tablets containing compacted starch as binder-disintegrant ingredient | |
| EP1847260B1 (en) | Solid dispersion preparation | |
| CA1117418A (en) | Antacid tablet formulation | |
| US5087454A (en) | Ibuprofen tablet | |
| AU702585B2 (en) | Pharmaceutical formulations of cefaclor | |
| US5470580A (en) | Directly-compressible naproxen or naproxen sodium compositions | |
| IE42952B1 (en) | Tablet formulation | |
| IL46629A (en) | Tablets comprising a 2,4-diaminopyrimidine and a sulphonamide | |
| EP0064388B1 (en) | Retard oral pharmaceutical compositions | |
| GB2124078A (en) | Processes for preparing tablets by a modified wet-granulation technique | |
| Ford et al. | Preparation, properties and ageing of tablets prepared from the chlorpropamide-urea solid dispersion | |
| IE42958B1 (en) | Tablet formulation | |
| JPS6328414B2 (https=) | ||
| Chowhan et al. | Effect of intergranular versus intragranular cornstarch on tablet friability and in vitro dissolution | |
| Bamiro et al. | Assessment of compressional, mechanical and release properties of Terminalia randii gum in paracetamol tablet formulation | |
| JP2007197373A (ja) | 口腔内速崩錠の製造方法 | |
| Majekodunmi et al. | Development of Novel Drug Delivery System Using Calcium Silicate | |
| Rubinstein et al. | The effect of four tablet binders on the bioavailability of frusemide from 40MG tablets | |
| Banakar | Evaluation of a low and a high density polyethylene as potential prolonged release tablet excipients | |
| Mohammed et al. | Evaluating the Flow and Release Profiles of Ibuprofen Formulations by Increasing the Binder Concentration | |
| JPH0291018A (ja) | 湿気に対して安定な固形バルプロ酸製剤とその製造法 |